Balance Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.7K Buy
+14
New +$10.6K ﹤0.01% 546

Other funds holding REGN

Balance Wealth's REGN Position: Q3 2026 in Review

Balance Wealth opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 14 shares worth $10.7K. The stake represents ﹤0.01% of the portfolio and ranks #546 among its holdings.

1,409 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Balance Wealth held 14 shares of Regeneron Pharmaceuticals worth $10.7K as of Q3 2026.
  • Regeneron Pharmaceuticals was a new Balance Wealth position in Q3 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Balance Wealth's portfolio in Q3 2026, its #546 holding.
  • 1,409 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Balance Wealth's 13F filing for Q3 2026, filed 27 Oct 2026.